Home > Insider Trading > Filing (0001567619-22-021291)

Filing Details

Accession Number:: 0001567619-22-021291
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-12-05 17:33:48
Reporting Period:: 2022-12-01

Accepted Time:: 2022-12-05 17:33:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1650648	4D Molecular Therapeutics Inc.	FDMT	Biological Products, (No Disgnostic Substances) (2836)	473506994

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1920738	Scott Bizily	C/O 4D Molecular Therapeutics Inc. 5858 Horton Street #455 Emeryville CA 94608	Chief Legal And Hr Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-12-01	1,875	$6.49	4,732	No	4	M	Direct
Common Stock	Disposition	2022-12-01	400	$21.52	4,332	No	4	S	Direct
Common Stock	Disposition	2022-12-01	975	$22.71	3,357	No	4	S	Direct
Common Stock	Disposition	2022-12-01	400	$23.25	2,957	No	4	S	Direct
Common Stock	Disposition	2022-12-01	100	$24.49	2,857	No	4	S	Direct
Common Stock	Acquisiton	2022-12-01	3,750	$8.04	6,607	No	4	M	Direct
Common Stock	Disposition	2022-12-01	1,000	$21.78	5,607	No	4	S	Direct
Common Stock	Disposition	2022-12-01	2,450	$22.93	3,157	No	4	S	Direct
Common Stock	Disposition	2022-12-01	200	$23.44	2,957	No	4	S	Direct
Common Stock	Disposition	2022-12-01	100	$24.49	2,857	No	4	S	Direct
Common Stock	Disposition	2022-12-01	375	$24.35	2,482	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2022-12-01	1,875	$0.00	1,875	$6.49
Common Stock	Stock Option (Right to Buy)	Disposition	2022-12-01	3,750	$0.00	3,750	$8.04

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
22,125		2032-06-17	No	4	M	Direct
56,250		2032-08-31	No	4	M	Direct

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
The transaction was executed in multiple trades in prices ranging from $20.92 to $21.79, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The transaction was executed in multiple trades in prices ranging from $22.13 to $23.11, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The transaction was executed in multiple trades in prices ranging from $23.16 to $23.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The transaction was executed in multiple trades in prices ranging from $21.21 to $22.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The transaction was executed in multiple trades in prices ranging from $22.39 to $23.36, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of June 16, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.
The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.
Reflects 2,857 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.